1. Home
  2. MAIA vs DVLT Comparison

MAIA vs DVLT Comparison

Compare MAIA & DVLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • DVLT
  • Stock Information
  • Founded
  • MAIA 2018
  • DVLT 2010
  • Country
  • MAIA United States
  • DVLT United States
  • Employees
  • MAIA N/A
  • DVLT N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • DVLT
  • Sector
  • MAIA Health Care
  • DVLT
  • Exchange
  • MAIA Nasdaq
  • DVLT NYSE
  • Market Cap
  • MAIA 46.7M
  • DVLT 51.5M
  • IPO Year
  • MAIA 2022
  • DVLT N/A
  • Fundamental
  • Price
  • MAIA $2.15
  • DVLT $0.76
  • Analyst Decision
  • MAIA
  • DVLT
  • Analyst Count
  • MAIA 0
  • DVLT 0
  • Target Price
  • MAIA N/A
  • DVLT N/A
  • AVG Volume (30 Days)
  • MAIA 79.7K
  • DVLT 335.4K
  • Earning Date
  • MAIA 05-13-2025
  • DVLT 05-20-2025
  • Dividend Yield
  • MAIA N/A
  • DVLT N/A
  • EPS Growth
  • MAIA N/A
  • DVLT N/A
  • EPS
  • MAIA N/A
  • DVLT N/A
  • Revenue
  • MAIA N/A
  • DVLT $2,674,000.00
  • Revenue This Year
  • MAIA N/A
  • DVLT $434.03
  • Revenue Next Year
  • MAIA N/A
  • DVLT $185.71
  • P/E Ratio
  • MAIA N/A
  • DVLT N/A
  • Revenue Growth
  • MAIA N/A
  • DVLT 28.37
  • 52 Week Low
  • MAIA $1.40
  • DVLT $0.60
  • 52 Week High
  • MAIA $5.99
  • DVLT $7.35
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 70.43
  • DVLT N/A
  • Support Level
  • MAIA $1.51
  • DVLT N/A
  • Resistance Level
  • MAIA $1.61
  • DVLT N/A
  • Average True Range (ATR)
  • MAIA 0.12
  • DVLT 0.00
  • MACD
  • MAIA 0.06
  • DVLT 0.00
  • Stochastic Oscillator
  • MAIA 90.91
  • DVLT 0.00

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About DVLT DATAVAULT AI INC

Datavault AI Inc is a data technology and licensing company that enables clients and strategic partners to monetize their Blockchain Data and AI Web 3.0 assets via tokenization, data ownership and digital twins offering two solutions: Data Science licenses High-Performance Computing (HPC) software applications and Web 3.0 data management serving the biotech, energy, education, fintech, real estate, and healthcare industries, among others. Acoustic Science licenses spatial and multichannel HD sound transmission, including proprietary brands ADIO, WiSA and Sumerian, to customers in sports & entertainment, events & venues, restaurants, automotive, finance, and other industries.

Share on Social Networks: